Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 540,856 | 584,177 | 690,648 | 491,041 | 578,929 |
| Marketable Securities | 392,888 | 335,901 | 369,432 | N/A | N/A |
| Receivables | 108,285 | 94,962 | 32,105 | 21,380 | 297,240 |
| Inventories | 8,749 | 8,638 | 9,172 | 15,778 | 41,696 |
| TOTAL | $1,128,942 | $1,103,680 | $1,203,370 | $727,120 | $1,143,888 |
| Non-Current Assets | |||||
| PPE Net | 138,413 | 285,724 | 288,559 | 291,093 | 305,771 |
| Intangibles | 107,478 | 126,766 | 123,377 | 123,179 | 127,454 |
| Other Non-Current Assets | 185,585 | 196,313 | 203,340 | 212,142 | 220,377 |
| TOTAL | $431,476 | $608,803 | $615,276 | $626,414 | $653,602 |
| Total Assets | $1,560,418 | $1,712,483 | $1,818,646 | $1,353,534 | $1,797,490 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 41,579 | 57,517 | 79,962 | 57,724 | 132,610 |
| Accrued Expenses | 211,165 | 218,674 | 159,221 | 257,365 | 394,668 |
| Other current liabilities | 219,596 | 281,715 | 242,811 | 242,102 | 861,408 |
| TOTAL | $1,154,416 | $1,180,999 | $1,157,811 | $804,382 | $1,635,138 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 675,067 | 613,418 | 666,390 | 240,900 | 241,310 |
| Other Non-Current Liabilities | 529,298 | 488,182 | 504,140 | 520,154 | 201,146 |
| TOTAL | $1,029,843 | $1,057,920 | $1,092,541 | $1,416,236 | $879,279 |
| Total Liabilities | $2,184,259 | $2,238,919 | $2,250,352 | $2,220,618 | $2,514,417 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,844 | 160,185 | 160,094 | 140,404 | 139,953 |
| Common Shares | 1,619 | 1,616 | 1,613 | 1,417 | 1,405 |
| Retained earnings | -5,008,450 | -4,927,420 | -4,806,120 | -4,968,501 | -4,820,951 |
| Other shareholders' equity | -22,413 | 3,738 | -10,947 | -10,775 | 2,455 |
| TOTAL | $-623,841 | $-526,436 | $-431,706 | $-867,084 | $-716,927 |
| Total Liabilities And Equity | $1,560,418 | $1,712,483 | $1,818,646 | $1,353,534 | $1,797,490 |